TAOK1
| Official symbol: | TAOK1 |
| Full name: | TAO kinase 1 |
| Location: | 17q11.2 |
| Also known as: | MARKK, FLJ14314, KIAA1361, PSK2, TAO1, MAP3K16 |
| Entrez ID: | 57551 |
| Ensembl ID: | ENSG00000160551 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.28 | | Gscore (Del): | 0.00 |
|
|
| Recurrently amplified in 1 cancer type(s) | |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
| Recurrently mutated in 1 cancer type(s) |
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 20 (Driver) |
|
|
| Fusions detected in 12 cancer type(s) |
|
| |
|
|
|
| Functional class: | Kinase (protein kinase) |
| JensenLab PubMed score: | 36.87 (Percentile rank: 57.48%) |
| PubTator score: | 19.66 (Percentile rank: 51.96%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
